Total planned funding: $645,579,594
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $645,579,594 |
Organizational Types
NGO | $168,138,454 |
Private Contractor | $163,868,454 |
Own Agency | $91,434,440 |
Host Country Government Agency | $74,016,310 |
University | $67,805,096 |
Unknown | $49,165,325 |
Parastatal | $14,662,124 |
Other USG Agency | $10,671,352 |
Multi-lateral Agency | $3,523,758 |
Implementing Agency | $1,160,959 |
FBO | $1,133,322 |
Program Areas
Treatment | $198,010,588 |
Care | $133,867,337 |
Prevention | $133,391,297 |
Governance and Systems | $83,457,353 |
Management and Operations | $50,251,539 |
Testing | $46,601,480 |
Budget Codes
HTXS: Treatment: Adult Treatment | $164,594,136 |
HKID: Care: Orphans and Vulnerable Children | $57,930,357 |
HVMS: Management and Operations | $50,251,539 |
HVCT: Testing: HIV Testing and Counseling | $46,601,480 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $43,721,759 |
HBHC: Care: Adult Care and Support | $42,759,746 |
HVOP: Sexual Prevention: Other Sexual Prevention | $37,100,714 |
HVSI: Strategic Information | $36,045,490 |
OHSS: Health Systems Strengthening | $34,537,473 |
HVTB: Care: TB/HIV | $23,060,772 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,336,682 |
HTXD: Treatment: ARV Drugs | $21,218,144 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,924,215 |
HLAB: Laboratory Infrastructure | $12,874,390 |
PDTX: Treatment: Pediatric Treatment | $12,198,308 |
PDCS: Care: Pediatric Care and Support | $10,116,462 |
HMBL: Biomedical Prevention: Blood Safety | $7,571,440 |
HMIN: Biomedical Prevention: Injection Safety | $3,736,487 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$83,615,734
Countries/Regions
University of Washington:
$50,050,031
Countries/Regions
Pact, Inc.:
$40,628,179
Countries/Regions